The Economist Such outfits are normally “burial grounds” for innovative ideas on drug policy, says Ethan Nadelmann, head of the Drug Policy Alliance, a pro-legalisation group. Countries such as Uruguay, which later this year may become the first to legalise the ... and more »
Business Wire (press release) Winners of the competition will partner with investigators on GSK's Discovery Partnerships with Academia (DPAc) team with a goal of developing viable research-stage drug candidates into innovative medicines. “We are excited to receive submissions in ...
HealthCanal.com The plaque is to be targeted and removed by illuminating a newly developed drug with infrared light. Jørn Bolstad Christensen has high expectations for the project's outcome. “If everything goes as planned, it should only be about five years before we ...
